Download the new eBook, “10 Steps to Better Alzheimer’s Disease Research.” Discover substantial opportunities to improve research studies and the lives of the 47 million people living with Alzheimer’s disease and related dementia.
The experts at Worldwide share 40 years of uncommon tenacity in Alzheimer’s disease research. Learn from their proactive approach, and you’ll be on your way to:
- Innovating clinical trial design to enhance signal detection and efficiency
- Improving screen failure in early-stage disease studies – particularly for potential disease modifying agents, and
- Limiting high variability across patient phenotypes in managing cognitive assessments
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit worldwide.com.